May 1, 2026
Willkie represented Caris Life Sciences (NASDAQ: CAI), a leader in molecular profiling for diagnosing and treating cancer, in connection with its $1.2 billion credit facility agented by Blue Owl Capital Corporation, providing for senior secured credit facilities consisting of $400 million in initial term loans, $300 million in Delayed Draw Term Loans and $500 million in uncommitted incremental term loans. Proceeds from the initial term loans were used to pay off Caris’s existing third-party debt and for general corporate purposes.
The Willkie team was led by partner Gus Atiyah and included counsel Nathan Wood and associates Ashley Shan and Salvatore Mancuso.
The Willkie team was led by partner Gus Atiyah and included counsel Nathan Wood and associates Ashley Shan and Salvatore Mancuso.
